Clinical Trial

Hepatic Arterial Infusion Chemotherapy in Patients With Inoperable Colorectal Cancer Liver Metastasis

Study acronym: HAIP-6192
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to assess how many patients with initially inoperable colorectal liver metastasis are able to have a liver surgery after treatment with hepatic artery infusion chemotherapy and standard of care systemic chemotherapy.
Trial Details
NCT Number NCT07764497
Lead Sponsor Sunnybrook Health Sciences Centre
Conditions Colorectal Adenocarcinoma Metastatic in the Liver, Liver Metastasis Colon Cancer, Liver Metastases From Colorectal Cancer, Liver Metastases of Colorectal Cancer
Enrollment 200 participants
Start Date 2014-07
Primary Completion 2036-12 (estimated)
Study Completion 2036-12 (estimated)
Updated on ClinicalTrials.gov 2026-08-14